Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Abroad (travel likely)Recruiting

Conditions

PD - Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California San Francisco, San Francisco, California, United States
Contact: Study coordinator (Sarah Wang, PhD) · sarah.wang@ucsf.edu · 415-353-7885

Study leads

Simon Little, MBBS,PhD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Parkinson's Disease (PD) · Parkinson's Disease · Parkinson's Disease (Disorder)

Abroad (travel likely)RecruitingEARLY_PHASE1

New Haven, United States · New Haven, United States

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Austin, United States · Tōon, Japan

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

Parkinson's Disease · Mild Cognitive Impairment

Abroad (travel likely)Recruiting

Zurich, Switzerland

Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Parkinson Disease · Parkinson's Disease

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea